| The medically examined applicant for private insurance and his/her right to informed consent: a comparative analysis. | |
| | |
MedLine Citation:
|
PMID: 21870593 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Within the context of health and insurance law, an important question that arises is "to what extent is an applicant for private insurance truly capable of giving his/her 'free' and informed consent for a medical examination?". It should be borne in mind that it is the private insurer who requires a medical examination in order to gather medical information, and, moreover, that the insurer will not be inclined to conclude or carry out an insurance contract without this medical information. A distinction has to be made between not being free by legal coercion and not being (completely) free by factual circumstances. Exercising the right to informed consent involves exactly weighing up the consequences of the decision. Hence the applicant must be put in a position of being able to weigh up the consequences and take them into consideration. |
| | |
Authors:
|
Sarah Defloor |
Related Documents
:
|
15008583 - Parasomnias in childhood. 21990173 - Rethinking resident supervision to improve safety: from hierarchical to interprofession... 10274173 - Medication carts--are they all the same? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European journal of health law Volume: 18 ISSN: 0929-0273 ISO Abbreviation: Eur J Health Law Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-08-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9431861 Medline TA: Eur J Health Law Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 319-30 Citation Subset: IM |
Affiliation:
|
Centre for Biomedical Ethics and Law, Catholic University of Leuven, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Access to advanced therapy medicinal products in the EU: where do we stand?
Next Document: [Computer modeling of the promising inhibitors of the HIV-1 subtype A replication as a framework for...